| 【Company Research】Fulu Holdings Ltd. (2101 HK) – One-stop virtual goods boutique |
| 【Sector Research】China Property Sector – What and when property tax will be? |
| 【Company Research】Tencent (700 HK) – Stepping into investment phase |
| 【Company Research】Glodon (002410 CH) – Expanding into digital design software |
| 【Company Research】GDS (9698 HK) – Growing fast despite near term regulation impact increasing |
| 【Company Research】I-Mab BioPharma (IMAB US) – Uliledlimab disclosed promising data from the US phase I study |
| 【Company Research】GDS (GDS US) – Growing fast despite near term regulatory impact |
| 【Company Research】ZTO Express (ZTO US) – Solid 1Q21 volume with resilient ASP |
| 【Company Research】ZTO Express (2057 HK) – Solid 1Q21 volume with resilient ASP |
| 【Company Research】Antengene Corporation Limited (6996 HK) – License in global rights of an oral CD73 inhibitor |
Address: 45th & 46th Floor, Champion Tower, 3 Garden Road, Central, Hong Kong
Telephone: （852）3900 0888 Fax:（852）3761 8788
Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
